Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin R tenOever

Showing results (71-80 of 124) with videos related to

Pageof 13
Sort By:
Science Immunology|September 9, 2022
Sensing of SARS-CoV-2 by pDCs and their subsequent production of IFN-I contribute to macrophage-induced cytokine storm during COVID-19Paôline Laurent, Chao Yang, André F Rendeiro, et al.
Nature|June 29, 2017
RNase III nucleases from diverse kingdoms serve as antiviral effectorsLauren C Aguado, Sonja Schmid, Jared May, et al.
JCI Insight|February 8, 2022
Disulfiram inhibits neutrophil extracellular trap formation and protects rodents from acute lung injury and SARS-CoV-2 infectionJose M Adrover, Lucia Carrau, Juliane Daßler-Plenker, et al.
Journal of Virology|June 9, 2017
Novel Cross-Reactive Monoclonal Antibodies against Ebolavirus Glycoproteins Show Protection in a Murine Challenge ModelJames Duehr, Teddy John Wohlbold, Lisa Oestereich, et al.
Elife|March 16, 2022
Coagulation factors directly cleave SARS-CoV-2 spike and enhance viral entryEdward R Kastenhuber, Marisa Mercadante, Benjamin Nilsson-Payant, et al.
Nature Cell Biology|March 15, 2023
A multi-organoid platform identifies CIART as a key factor for SARS-CoV-2 infectionXuming Tang, Dongxiang Xue, Tuo Zhang, et al.
Nature Biotechnology|August 13, 2013
MicroRNA-based strategy to mitigate the risk of gain-of-function influenza studiesRyan A Langlois, Randy A Albrecht, Brian Kimble, et al.
Biorxiv : the Preprint Server for Biology|February 17, 2021
Disruption of nuclear architecture as a cause of COVID-19 induced anosmiaMarianna Zazhytska, Albana Kodra, Daisy A Hoagland, et al.
Cancer Cell|October 31, 2003
VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agentsDavid F Stojdl, Brian D Lichty, Benjamin R tenOever, et al.
Cell|May 17, 2020
Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19Daniel Blanco-Melo, Benjamin E Nilsson-Payant, Wen-Chun Liu, et al.
Pageof 13

Showing results (71-80 of 124) with videos related to

Sort By:
Pageof 13
Science Immunology|September 9, 2022
Sensing of SARS-CoV-2 by pDCs and their subsequent production of IFN-I contribute to macrophage-induced cytokine storm during COVID-19Paôline Laurent, Chao Yang, André F Rendeiro, et al.
Nature|June 29, 2017
RNase III nucleases from diverse kingdoms serve as antiviral effectorsLauren C Aguado, Sonja Schmid, Jared May, et al.
JCI Insight|February 8, 2022
Disulfiram inhibits neutrophil extracellular trap formation and protects rodents from acute lung injury and SARS-CoV-2 infectionJose M Adrover, Lucia Carrau, Juliane Daßler-Plenker, et al.
Journal of Virology|June 9, 2017
Novel Cross-Reactive Monoclonal Antibodies against Ebolavirus Glycoproteins Show Protection in a Murine Challenge ModelJames Duehr, Teddy John Wohlbold, Lisa Oestereich, et al.
Elife|March 16, 2022
Coagulation factors directly cleave SARS-CoV-2 spike and enhance viral entryEdward R Kastenhuber, Marisa Mercadante, Benjamin Nilsson-Payant, et al.
Nature Cell Biology|March 15, 2023
A multi-organoid platform identifies CIART as a key factor for SARS-CoV-2 infectionXuming Tang, Dongxiang Xue, Tuo Zhang, et al.
Nature Biotechnology|August 13, 2013
MicroRNA-based strategy to mitigate the risk of gain-of-function influenza studiesRyan A Langlois, Randy A Albrecht, Brian Kimble, et al.
Biorxiv : the Preprint Server for Biology|February 17, 2021
Disruption of nuclear architecture as a cause of COVID-19 induced anosmiaMarianna Zazhytska, Albana Kodra, Daisy A Hoagland, et al.
Cancer Cell|October 31, 2003
VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agentsDavid F Stojdl, Brian D Lichty, Benjamin R tenOever, et al.
Cell|May 17, 2020
Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19Daniel Blanco-Melo, Benjamin E Nilsson-Payant, Wen-Chun Liu, et al.
Pageof 13